digital currency uk Overview

Azure lithium battery: Robot/dog is the application field of lithium battery that the company pays close attention to. At present, only a few shipments are used in this field. Robot/dog is the application field of lithium battery that the company pays close attention to. At present, only a few shipments are used in this field, accounting for a small proportion. At present, power tools, cleaning appliances and electric motorcycles are the main applications.Twenty-five pilot banks in Shenzhen have opened a total of 64,000 cross-border wealth management accounts. The reporter was informed that by the end of November 2024, 25 pilot banks in Shenzhen had opened a total of 64,000 cross-border wealth management accounts, with a total amount of cross-border receipts and payments of 42.74 billion yuan, accounting for 48.1% and 44.2% of Guangdong-Hong Kong-Macao Greater Bay Area respectively.Huifa Food: Shareholder Zhenghechang Investment Co., Ltd.' s shareholding reduction plan has not been completed yet, and Huifa Food announced the change. On November 8, 2024, the company disclosed the Announcement of Huifa Food Shareholder's shareholding reduction plan, and Shareholder Zhenghechang Investment Co., Ltd. plans to reduce its shareholding by centralized bidding to no more than 2,446,423 shares, which does not exceed 1% of the company's total share capital; The reduction of holdings through block trading does not exceed 4,892,846 shares, and does not exceed 2% of the company's total share capital. The planned reduction period is from November 29, 2024 to February 27, 2025. As of December 13, 2024, shareholder Zhenghechang Investment Co., Ltd. has reduced its shareholding by 1.7 million shares through centralized bidding. At present, the shareholder's shareholding reduction plan has not been completed.

Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.The Kuala Lumpur Composite Index of Malaysia closed up 0.4% at 1,608.75.Before the US stock market: China ETF-Direxion fell by nearly 4% and Broadcom rose by about 14% when it was three times richer. Before the US stock market, China Stock Exchange fell by about 3% and Pinduoduo fell by about 1%. Broadcom rose by about 14%, the company's Q4 profit exceeded expectations, and AI revenue in the whole fiscal year doubled by 220%.

The Kuala Lumpur Composite Index of Malaysia closed up 0.4% at 1,608.75.Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.Du Zhaocai, former deputy director of the State Sports General Administration, was sentenced to 14 years' imprisonment and fined 4 million yuan. On December 13, 2024, Wuhan Intermediate People's Court of Hubei Province publicly pronounced the bribery case of Du Zhaocai, former party member and deputy director of the State Sports General Administration and former party secretary and vice chairman of the Chinese Football Association, and sentenced the defendant Du Zhaocai to 14 years' imprisonment and fined 4 million yuan. The property and fruits of his crime shall be recovered according to law and turned over to the state treasury. It was found through trial that from 2012 to 2022, the defendant Du Zhaocai took advantage of his position as Party Secretary and Director of the Athletics Management Center of the State Sports General Administration, Vice Chairman and Secretary General of the Chinese Athletics Association, member of the Party Committee of the State Sports General Administration, assistant to the director, deputy director, and Party Secretary and Vice Chairman of the Chinese Football Association to provide assistance to relevant units and individuals in matters such as event hosting, personnel arrangement, player transfer, etc., and illegally accepted other people's property totaling RMB 4,341. (CCTV News)